Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited

Summary Background Treatment of relapsed hematological malignancies after an allogeneic peripheral blood stem cell transplant (SCT) is challenging. Donor lymphocyte infusion (DLI) from the stem cell donor is an attractive clinical option to salvage this group of patients. Methods We reviewed the imp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer treatment reviews 2010-11, Vol.36 (7), p.528-538
Hauptverfasser:	Deol, Abhinav, Lum, Lawrence G
Format:	Artikel
Sprache:	eng
Schlagworte:	Chronic myeloid leukemia Donor lymphocyte infusion Donor lymphocyte transfusion Graft vs Host Disease - etiology Graft vs. host disease Graft vs. leukemia Hematology, Oncology and Palliative Medicine Hematopoietic Stem Cell Transplantation Humans Immunotherapy Leukemia - therapy Lymphocyte Transfusion - adverse effects Lymphoma - therapy Multiple Myeloma - therapy Recurrence T cells Tissue Donors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!